Arkolith/Insider Trading/BOLT/Form 4

Nemec Sarah

Senior VP, Finance and PAOBolt Biotherapeutics, Inc. (BOLT) · full profile →Form 4 · filed Feb 4, 2026
Net Buying
Open-Market Buys
$576
Open-Market Sells
$0
Net Open-Market Flow
$576
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 5, 2025Buy(P)125$4.61$5761K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 28, 2026Grant(A)8K—$08K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-037690) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML